Manufacturer
Alnylam Pharmaceuticals
Pharmaceutical manufacturer based in United States
United States
- Products listed
- 4
- Molecules
- 4
- Therapy areas
- 2
Alnylam Pharmaceuticals is a pharmaceutical manufacturer based in United States. MedsAcross lists 4 of its products across 4 molecules, each with registers, packs and availability for export supply to licensed buyers.
- Country
- United States
- Indian manufacturer
- No
- Also listed as
- Alnylam Pharmaceuticals, Inc.
- US FDA labeler
- YesSource: openFDA NDC directory
Source from this manufacturer
We supply Alnylam Pharmaceuticals products through licensed channels, with the documents your regulator needs.
Neurology
2 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Amvuttra 25 mg/0.5 mL injectionSubcutaneous | Vutrisiran | US FDA | Available on request |
| Onpattro 10 mg/5 mL lipid complex injectionIntravenous Cold chain | Patisiran | US FDA | Available on request |
Rare diseases and enzyme replacement
2 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Givlaari 189 mg/1 mL injectionSubcutaneous | Givosiran | US FDA | Available on request |
| Oxlumo 94.5 mg/0.5 mL injectionSubcutaneous | Lumasiran | US FDA | Available on request |
Molecules made
Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.
Source from Alnylam Pharmaceuticals
Send a request for any of these products. We confirm the licensed source, documents and lead time.